Clinical Trials Browser

OTHER × Stomach Neoplasms × trastuzumab deruxtecan × Clear all

NCT06085755 2025-12-15

Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer

Phase 1/2 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT06630130 2025-12-15

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT05965479 2024-11-12

DECIPHER

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Neoplasm, Residual